IRIS

FRANCESCHI, MARIA CRISTINA

FRANCESCHI, MARIA CRISTINA  

Mostra records
Risultati 1 - 20 di 42 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autore(i) File
10 Day bismuth-based quadruple therapy for HP eradication in comparison with other therapies in a population with high clarithromycin resistance in northeast Italy 1-gen-2017 Franceschi, M.; Ferronato, A.; Baldassarre, A. Tursi G.; Miraglia, C.; Tomba, F.; Busellato, V.; Scida, S.; Sella, D.; Panozzo, M.; Antico, A.; Gasparri, L.; Visonà, A.; Di Mario, F.
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 1-gen-1993 Dotto, P.; Battaglia, G.; Franceschi, M.; Vigneri, S.; Ferrana, M.; Salandin, S.; Dal Bo, N.; Grasso, G. A.; Vianello, F.; Plebani, M.; Guido, M.; Rugge, M.; Di Mario, F.
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers 1-gen-1996 Pilotto, A; Di Mario, F; Franceschi, M; Leandro, G; Soffiati, G; Scagnelli, M; Bozzola, L; Valerio, G
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D 1-gen-1998 Di Mario, F; Buda, A; Dal Bò, N; De Bastiani, R; Grassi, Sa; Crestani, B; Battaglia, G; Pilotto, A; Franceschi, M; De Bona, M; Salandin, S
Helicobacter pylori infection in asymptomatic elderly subjects living at home or in a nursing home: effects on gastric function and nutritional status 1-gen-1996 Pilott, A; Fabrello, R; Franceschi, M; Scagnelli, M; Soffiati, CESARE FRANCESCO; Di Mario, F; Fortunato, A; Valerio, G
La terapia delle malattie acido-correlate nell'anziano 1-gen-2005 Pilotto, Alberto; Franceschi, M.; Orsitto, G.; Di Mario, F.
LONG-TERM TREATMENT WITH MESALAMINE IN DIVERTICULAR DISEASE: A FIVE YEARS FOLLOW-UP STUDY 1-gen-2009 Curlo, M.; Guida, L.; Cirillo, A.; Gatta, L.; Papadia, C.; Vaira, D.; Pilotto, A.; Franceschi, M.; Cavestro, G. M.; Franzè, A.; Di Mario, F.
OC.07.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM® ADMINISTRATION: A 2 YEAR PROSPECTIVE STUDY IN PATIENTS WITH CHRONIC, ATROPHIC, BODY GASTRITIS 1-gen-2016 Di Mario, F.; Ricco, M.; Dal Bo, N.; Ferrara, F.; Marcello, R.; Grande, G.; Franceschi, M.; Scarpignato, C.; Rugge, M.
OC.09.2: Appropriateness of PPI Administration in the Elderly: Evaluation of Acid Secretion and Atrophic Gastritis by Means of a Non-Invasive Test 1-gen-2017 Franceschi, M.; Goni, E.; Speroni, Simone; Pilotto, A.; Baldassarre, G.; Antico, A.; Panozzo, P.; Grillo, S.; Landi, S.; Scarpignato, C.; Corrente, V.; Rugge, M.; Di Mario, F.
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients 1-gen-2017 Di Mario, F.; Savarino, E.; Miraglia, C.; De Bortoli, N.; Franceschi, M.; Scida, S.; Grillo, S.; Landi, S.; Corrente, V.; Savarino, V.; Bertelè, A.; Scarpignato, C.
P.01.5: Serum Pepsinogen II as a Non-Invasive Marker for Diagnosis of Helicobacter Pylori Infection: A Prospective Study in a Cohort of Dyspeptic Patients 1-gen-2017 Grillo, S.; Landi, S.; Violi, A.; Franceschi, M.; Masciangelo, G.; Baldassarre, G.; Rugge, M.; Crafa, P.; Corrente, V.; Tursi, A.; Brandimarte, G.; Scarpignato, C.; Dal Bò, N.; Cannizzaro, R.; Di Mario, F.
P.01.7: Efficacy of PPIS and H-2 Blockers Therapy on Acid Suppression Assessed by Gastrin-17 and Pepsinogen I Serum Levels Determination in Gerd Patients 1-gen-2017 Landi, S.; Grillo, S.; Violi, A.; Masciangelo, G.; Scarpignato, C.; Corrente, V.; Panozzo, P.; Franceschi, M.; Bertelè, A.; Di Mario, F.
P.02.10: Bismuth-Containing Quadruple Therapy in Patients Infected by Helicobacter Pylori: A First Real Life Italian Experience 1-gen-2017 Tursi, A.; Franceschi, M.; De Bastiani, R.; Elisei, W.; Baldassarre, G.; Ferronato, A.; Grillo, S.; Landi, S.; Zamparella, M.; Boscariolo, L.; Picchio, M.; Di Mario, F.
P.02.15: The Role of Gastropanel in the Evaluation of the Appropriateness of Proton PUMP Inhibitor (PPI)-Therapy Prescription in a Primary Care Population 1-gen-2017 Franceschi, M.; Panozzo, M. P.; Di Mario, F.; Tomba, F.; Sella, D.; Antico, A.; Ferronato, A.; Baldassarre, G.
P.02.19: Prevalence of H. Pylori Infection, Chronic Atrophic Gastritis and Reflux Disease in a Primary Care Population of North-East Italy with Serum Biomarker Panel (Gastropanel®) 1-gen-2017 Baldassarre, G.; Panozzo, M. P.; Santacatterina, Marta; Tomba, F.; Sella, D.; Ferronato, A.; Antico, ALESSANDRA MICHELA; Di Mario, F.; Franceschi, MARIA CRISTINA
P.02.1: Individual Assessment of Gastric Acid Production by Means of a Non-Invasive Test: Relationship Between Maximal Acid Output and Serum Pepsinogen I Levels in Patients with Different Upper GI Diseases 1-gen-2017 Di Mario, F.; Scida, S.; Miraglia, C.; Franceschi, M.; Bertelè, A.; Cannizzaro, R.; Dal Bò, N.; Savarino, E.; De Bortoli, N.; Rugge, M.; Scarpignato, C.
P.02.2: Improvement of Symptoms in Patients Affected by Chronic Athrophic Gastritis: A 2 Years Prospective Study by using L-Cysteine (Acetium™) 1-gen-2017 Grillo, S.; Landi, S.; Miraglia, C.; Crafa, P.; Scida, S.; Franceschi, M.; Cannizzaro, R.; Goni, E.; Dal Bò, N.; Scarpignato, C.; Rugge, M.; Di Mario, F.
P.02.5: PPI Test for Diagnosis of Body Atrophic Gastritis: A Prospective Study 1-gen-2017 Di Mario, F.; Landi, S.; Grillo, S.; Corrente, V.; Franceschi, M.; Baldassarre, G.; Grande, G.; Cannizzaro, R.; Rugge, M.
P.02.7: The Branded Proton Pump Inhibitors (PPIS) Increase Levels of Gastrin 17 (G-17) More than the Generic Ones in Dyspeptic Patients from an Italian Primary Care Population 1-gen-2017 Di Mario, F.; Panozzo, M. P.; Baldassarre, G.; Antico, A.; Tursi, Andrea; Brandimarte, G.; Scarpignato, C.; Tomba, F.; Franceschi, M.
P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination 1-gen-2017 Franceschi, M.; Panozzo, P.; Miraglia, C.; Antico, A.; Baldassarre, G.; Scida, S.; Uziel, Elad; Grillo, S.; Landi, S.; Cannizzaro, R.; Crafa, P.; Scarpignato, C.; Rugge, M.; Di Mario, F.